SNShuet Fong Neong

Shuet Fong Neong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shuet Fong Neong has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Anand Ghanekar

    Multi-Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada

    1 shared publication
  • Bettina E. Hansen

    Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

    1 shared publication
  • Dagmar Kollmann

    Department of General Surgery, Gastroesophageal Tumor Unit-Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria

    1 shared publication
  • David R. Grant

    Multi-Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada

    1 shared publication
  • Emma O. Billington

    Division of Endocrinology & Metabolism, Department of Medicine, University of Calgary, Calgary, AB, Canada

    1 shared publication
  • Florence Wong

    Department of Medicine, University of Toronto, Toronto, Canada

    1 shared publication

Latest Publications

  • Open Access

    Renal Dysfunction After Liver Transplantation: Effect of Donor Type

    by Dagmar Kollmann, Shuet Fong Neong, Roizar Rosales, Bettina E. Hansen, Gonzalo Sapisochin, Stuart McCluskey, Mamatha Bhat, Mark S. Cattral, Les Lilly, Ian D. McGilvray, et al.

    Recipients of donation after circulatory death (DCD) grafts are reportedly at higher risk of developing renal dysfunction after liver transplantation (LT). We compared the development of acute kidney injury (AKI) and chronic kidney disease (CKD) after LT in recipients of DCD versus donation after brain death (DBD) or living donor liver transplantation (LDLT) livers. Adult recipients of DBD, LDLT, and DCD between 2012 and 2016 at Toronto General Hospital were included. AKI was defined as a post‐LT increase of serum creatinine (sCr) ≥26.5 µmol/L within 48 hours or a ≥50% increase from baseline, and CKD was defined as an estimated glomerular filtration rate 3 months. A total of 681 patients (DCD, n = 57; DBD, n = 446; and LDLT, n = 178) with similar baseline comorbidities were included. Perioperative AKI (within the first 7 postoperative days) was observed more frequently in the DCD group (61%; DBD, 40%; and LDLT, 44%; P = 0.01) and was associated with significantly higher peak AST levels (P < 0.001). Additionally, patients in the DCD group had a significantly higher peak sCr (P < 0.001) and a trend toward higher rates of AKI stage 3 (DCD, 33%; DBD, 21%; LDLT, 21%; P = 0.11). The proportions of recovery from AKI (DCD, 77%; DBD, 72%; LDLT, 78%; P = 0.45) and patients developing CKD (DCD, 33%; DBD, 32%; LDLT, 32%; P = 0.99) were similar. Nevertheless, patients who received DCD or DBD LT and required perioperative renal replacement therapy showed significantly lower patient survival in multivariate analysis (hazard ratio, 7.90; 95% confidence interval, 4.51‐13.83; P < 0.001). In conclusion, recipients of DCD liver grafts experience higher rates of short‐term post‐LT renal dysfunction compared with DBD or LDLT. Additional risk factors for the development of severe kidney injury, such as high Model for End‐Stage Liver Disease score, massive transfusions, or donor age ≥60 years should be avoided.


  • Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management

    by Shuet Fong Neong, Emma O. Billington, Stephen E. Congly

    Healthy sexual function is important to maintain a good quality of life but is frequently impaired in patients with cirrhosis. The degree of sexual dysfunction appears to be linked with the degree of hepatic dysfunction. In men, sexual dysfunction can be related to the hyperestrogenism of portal hypertension and/or to decreased testosterone resulting from testicular dysfunction. In women, suppression of the hypothalamic–pituitary–gonadal axis appears to be a principal contributor, with no significant effect of portal hypertension. There is also a huge psychological barrier to break through as there is a component of depression in many patients with cirrhosis. Sexual dysfunction is often underdiagnosed in the cohort with cirrhosis. Management of sexual disorders in patients with cirrhosis can be challenging as they are often multifactorial. A multidisciplinary approach is key in managing these patients. We review the current literature on the pathogenesis of sexual dysfunction in patients with cirrhosis and propose a stepwise algorithm to better manage these patients.